Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Varenicline and Bupropion for Smoking Cessation
NCT00935818Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Sep 2009; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00935818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935818.